CIK 0001869105
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
BridgeBio Oncology Therapeutics, Inc.
Sign in to watch- Ticker
- BBOT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-702-0377
- Business address
- 256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Helix Acquisition Corp. II
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,628
- in 2 filings, $4K under 10b5-1 plans
Net −$3,628. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-13 | Cobo Marc Principal Accounting Officer | Sale 10b5-1 | −78 | $2.37 | $185 | 13,734 |
| 2026-10-21 | Cobo Marc Principal Accounting Officer | Shares withheld for taxes | −203 | $2.68 | $544 | 13,812 |
| 2026-10-01 | Cobo Marc Principal Accounting Officer | Shares withheld for taxes | −126 | $3.94 | $496 | 14,015 |
| 2026-09-10 | Cobo Marc Principal Accounting Officer | Grant or award | +9,038 | 14,344 | ||
| 2026-09-10 | Cobo Marc Principal Accounting Officer | Shares withheld for taxes | −203 | $5.52 | $1K | 14,141 |
| 2026-09-10 | Cobo Marc Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +43,700 | 43,700 | ||
| 2026-07-01 | Cobo Marc Principal Accounting Officer | Shares withheld for taxes | −125 | $7.80 | $975 | 5,306 |
Page 1 of 1 · 7 trades